Logotype for Suzano S.A

Suzano (SUZB3) Q3 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Suzano S.A

Q3 2025 earnings summary

7 Nov, 2025

Executive summary

  • Achieved a 7% year-over-year reduction in cash cost, now below BRL 800 per ton, driven by operational efficiencies, lower wood and input costs, and FX appreciation.

  • Adjusted EBITDA reached R$5.2 billion, down 20% year-over-year, mainly due to lower pulp prices and currency depreciation, partially offset by higher sales volumes and improved efficiency.

  • Net income was R$1,961 million, a 39% decrease year-over-year, reflecting lower financial results and reduced net revenue.

  • US packaging business and paperboard assets delivered their first positive EBITDA since acquisition.

  • Focus remains on extracting value from recent investments, including Suzano Packaging, the new tissue mill in Aracruz, and the JV with Cascades.

Financial highlights

  • Leverage in dollar terms increased to 3.3x due to lower LTM EBITDA from reduced pulp prices, while net debt remained stable quarter-on-quarter.

  • Adjusted EBITDA margin was 43%, down from 53% a year ago; free cash flow yield (LTM) was 18.1%, up 1.2 p.p. year-over-year.

  • Liquidity stood at US$6.5 billion, up from US$5.7 billion a year ago.

  • Issued $1 billion in new 10-year bonds at the lowest corporate spread in company history and repurchased short-term bonds, extending average debt maturity to 80 months at a stable 5% cost.

  • Net revenue totaled R$12,153 million, a 1% decrease year-over-year, with 81% from exports.

Outlook and guidance

  • Confident in delivering the most competitive quarterly cash cost in Q4 2024-2025 and maintaining a full-year average near Q4 2024 levels.

  • CAPEX guidance for 2025 reaffirmed at BRL 13.3 billion, with a declining trend expected for 2026 as major projects conclude.

  • Further reduction in cash production cost expected for 4Q25, with continued focus on operational efficiency and cost control.

  • New tissue mill in Aracruz and JV with K-C/Cascades progressing as planned, with benefits expected from 4Q25.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more